Beverley Carr
Interim Chief Executive Officer, Chief Business and Operating Officer
Meet our Leadership Team
Our Leadership Team are reshaping the future direction of TPD drug development. Their combined skills and experience from leading Pharma and Biotech companies is empowering Amphista to achieve its vision of delivering TPD medicines to patients.
Louise Modis
Chief Scientific Officer
Martin Pass
Chief Development Officer
Giles Brown
Senior VP Chemistry
